WallStreetZenWallStreetZen

NASDAQ: ORGO
Organogenesis Holdings Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Organogenesis Holdings revenue was $564.17M for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2025) ending on Dec 31, 2025 was $225.6M, up 49.5% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, ORGO annual revenue was $564.2M, with 17% growth year-over-year.

ORGO past revenue growth

How has ORGO's revenue growth performed historically?

Company
17.04%
Industry
4.32%
Market
91.52%
ORGO's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
ORGO's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
ORGO's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

ORGO revenue history

Current Revenue
$564.2M
Current Earnings
$20.0M
Current Profit Margin
3.5%

Be the first to know when ORGO announces revenue.

ORGO Revenue History By Year

ORGO Yearly RevenueORGO RevenueORGO ChangeORGO Revenue Growth
2025-12-31$564.17M$82.13M+17.04%
2024-12-31$482.04M$48.90M+11.29%
2023-12-31$433.14M-$17.75M-3.94%
2022-12-31$450.89M-$16.47M-3.52%
2021-12-31$467.36M$129.06M+38.15%
2020-12-31$338.30M$77.32M+29.63%
2019-12-31$260.98M$67.53M+34.91%
2018-12-31$193.45M-$5.06M-2.55%
2017-12-31$198.51M$59.78M+43.09%
2016-12-31$138.73MN/AN/A

1 of 1

Organogenesis Holdings Revenue FAQ

What was ORGO's revenue last quarter?

On Invalid Date, Organogenesis Holdings (NASDAQ: ORGO) reported Q4 2025 revenue of $225.61 million up 78.13% year over year. In the same quarter last year, Organogenesis Holdings's revenue was $126.66 million.

What was Organogenesis Holdings's revenue in 2025?

Organogenesis Holdings's annual revenue for the twelve months ending Dec 31, 2025 was $564.17 million, a 17.04% increase year over year.

How much does Organogenesis Holdings make in a day?

Based on Organogenesis Holdings annual revenue for the past five years, ORGO makes an average of $1,313,755.62 per day.

What was Organogenesis Holdings's annual revenue growth in the past year?

As of Q1 2026, Organogenesis Holdings's revenue has grown 17.04% year over year. This is 12.72 percentage points higher than the US Drug Manufacturers - Specialty & Generic industry revenue growth rate of 4.32%. Organogenesis Holdings's revenue in the past year totaled $564.17 million.

How much does Organogenesis Holdings make in a year?

Organogenesis Holdings's revenue by year for the past five years is:
  • Organogenesis Holdings's revenue for the twelve months ending Dec 31, 2025 was $564.17 million, a 17.04% increase year over year.
  • Organogenesis Holdings's annual revenue for Dec 31, 2024 was $482.04 million, a 11.29% increase from 2023.
  • Organogenesis Holdings's annual revenue for 2023 was $433.14 million, a 3.94% decrease from 2022.
  • Organogenesis Holdings's annual revenue for 2022 was $450.89 million, a 3.52% decrease from 2021.
  • Organogenesis Holdings's annual revenue for 2021 was $467.36 million, a 38.15% increase from 2020.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.